N-Butyloxycarbonyl-3-[4-(3-methyl-2,5-dioxoimidazolidin-1-yl-methyl)-phenyl]-5-iso-butyl-thiophene-2-sulfonamide

ID: ALA1165496

Chembl Id: CHEMBL1165496

Max Phase: Preclinical

Molecular Formula: C24H31N3O6S2

Molecular Weight: 521.66

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCOC(=O)NS(=O)(=O)c1sc(CC(C)C)cc1-c1ccc(CN2C(=O)CN(C)C2=O)cc1

Standard InChI:  InChI=1S/C24H31N3O6S2/c1-5-6-11-33-23(29)25-35(31,32)22-20(13-19(34-22)12-16(2)3)18-9-7-17(8-10-18)14-27-21(28)15-26(4)24(27)30/h7-10,13,16H,5-6,11-12,14-15H2,1-4H3,(H,25,29)

Standard InChI Key:  KTVAKYJUYIFQFY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA1165496

    ---

Associated Targets(Human)

CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Angiotensin type II receptor (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 521.66Molecular Weight (Monoisotopic): 521.1654AlogP: 4.22#Rotatable Bonds: 10
Polar Surface Area: 113.09Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.61CX Basic pKa: CX LogP: 4.68CX LogD: 3.74
Aromatic Rings: 2Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -0.77

References

1. Mahalingam AK, Wan Y, Murugaiah AM, Wallinder C, Wu X, Plouffe B, Botros M, Nyberg F, Hallberg A, Gallo-Payet N, Alterman M..  (2010)  Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.,  18  (12): [PMID:20493713] [10.1016/j.bmc.2010.03.064]

Source